Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Zura Bio Ltd changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 38 | 41 | +3 |
| Shares | 12.8M | 14.1M | +1.30M (+10.1%) |
| Value | $105.0M | $93.3M | −$11.7M (−11.1%) |
New holders (7)
Institutions that held Zura Bio Ltd at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 424,000 | $2.80M | 0.40% |
| Eisler Capital (US) LLC | 100,000 | $660.0K | 0.24% |
| Bank of New York Mellon Corp | 33,973 | $224.2K | 0.00% |
| Goldman Sachs Group Inc | 17,456 | $115.2K | 0.00% |
| Forefront Analytics, LLC | 14,464 | $95.5K | 0.05% |
| Lynx1 Capital Management LP | 9,917 | $65.5K | 0.04% |
| Russell Investments Group, Ltd. | 35 | $231 | 0.00% |
Sold out (4)
Institutions that held Zura Bio Ltd at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Eisler Capital (UK) Ltd. | 100,000 | $820.0K |
| Nuveen Asset Management, LLC | 17,250 | $141.4K |
| HRT Financial LP | 10,162 | $83.0K |
| Point72 Middle East FZE | 1,087 | $8.91K |